249 related articles for article (PubMed ID: 8203842)
1. Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.
Voorn GP; Kuyvenhoven J; Goessens WH; Schmal-Bauer WC; Broeders PH; Thompson J; Michel MF
Antimicrob Agents Chemother; 1994 Mar; 38(3):487-93. PubMed ID: 8203842
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
Voorn GP; Thompson J; Goessens WH; Schmal-Bauer WC; Broeders PH; Michel MF
J Antimicrob Chemother; 1994 Apr; 33(4):785-94. PubMed ID: 8056697
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Reddy VN; Bailey EM; Rybak MJ
Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
Cantoni L; Glauser MP; Bille J
Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
[TBL] [Abstract][Full Text] [Related]
6. Role of tolerance in cloxacillin treatment of experimental Staphylococcus aureus endocarditis.
Voorn GP; Thompson J; Goessens WH; Schmal-Bauer W; Broeders PH; Michel MF
J Infect Dis; 1991 Mar; 163(3):640-3. PubMed ID: 1995736
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Fernandez J; Abbanat D; Shang W; He W; Amsler K; Hastings J; Queenan AM; Melton JL; Barron AM; Flamm RK; Lynch AS
Antimicrob Agents Chemother; 2012 Mar; 56(3):1476-84. PubMed ID: 22232278
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Sakoulas G; Eliopoulos GM; Alder J; Eliopoulos CT
Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345
[TBL] [Abstract][Full Text] [Related]
9. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
Pavie J; Lefort A; Ploy MC; Massias L; Chau F; Garry L; Denis F; Fantin B
Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Marco F; de la Mària CG; Armero Y; Amat E; Soy D; Moreno A; del Río A; Almela M; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
Antimicrob Agents Chemother; 2008 Jul; 52(7):2538-43. PubMed ID: 18426900
[TBL] [Abstract][Full Text] [Related]
11. Role of tolerance in cloxacillin prophylaxis of experimental Staphylococcus aureus endocarditis.
Voorn GP; Thompson J; Goessens WH; Schmall-Bauer W; Broeders PH; Michel MF
J Infect Dis; 1992 Jul; 166(1):169-73. PubMed ID: 1607692
[TBL] [Abstract][Full Text] [Related]
12. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
Chambers HF; Sande MA
Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
[TBL] [Abstract][Full Text] [Related]
13. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
Schaad HJ; Chuard C; Vaudaux P; Waldvogel FA; Lew DP
Antimicrob Agents Chemother; 1994 Aug; 38(8):1703-10. PubMed ID: 7985998
[TBL] [Abstract][Full Text] [Related]
14. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
[TBL] [Abstract][Full Text] [Related]
15. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical dose effect of continuously administered cloxacillin in treatment of tolerant Staphylococcus aureus endocarditis in rats.
Voorn GP; Thompson J; Goessens WH; Schmal-Bauer WC; Broeders PH; Michel MF
J Antimicrob Chemother; 1994 Mar; 33(3):585-93. PubMed ID: 8040122
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.
McGrath BJ; Kang SL; Kaatz GW; Rybak MJ
Antimicrob Agents Chemother; 1994 Sep; 38(9):2034-40. PubMed ID: 7811015
[TBL] [Abstract][Full Text] [Related]
18. Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.
Perdikaris GS; Pefanis A; Giamarellou H; Nikolopoulos A; Margaris EP; Donta I; Tsitsika A; Karayiannakos P
Antimicrob Agents Chemother; 1997 Sep; 41(9):1916-21. PubMed ID: 9303384
[TBL] [Abstract][Full Text] [Related]
19. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
[TBL] [Abstract][Full Text] [Related]
20. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Galetto DW; Boscia JA; Kobasa WD; Kaye D
J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
